These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9826456)

  • 1. Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature.
    Iliszko M; Mandahl N; Mrózek K; Denis A; Pandis N; Pejovic T; Babińska M; Nedoszytko B; Debniak J; Emerich J; Hrabowska M; Bloomfield CD; Limon J
    Gynecol Oncol; 1998 Nov; 71(2):172-6. PubMed ID: 9826456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic profile of uterine sarcomas.
    Laxman R; Currie JL; Kurman RJ; Dudzinski M; Griffin CA
    Cancer; 1993 Feb; 71(4):1283-8. PubMed ID: 8382105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.
    Gunawan B; Baumhoer D; Schulten HJ; Emons G; Füzesi L
    Anticancer Res; 2003; 23(2B):1379-83. PubMed ID: 12820397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERBB-2 gene overexpression and amplification in uterine sarcomas.
    Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
    Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization.
    Halbwedl I; Ullmann R; Kremser ML; Man YG; Isadi-Moud N; Lax S; Denk H; Popper HH; Tavassoli FA; Moinfar F
    Gynecol Oncol; 2005 May; 97(2):582-7. PubMed ID: 15863163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature.
    Euscher ED; Deavers MT; Lopez-Terrada D; Lazar AJ; Silva EG; Malpica A
    Am J Surg Pathol; 2008 Feb; 32(2):219-28. PubMed ID: 18223324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex karyotypic alterations in an endometrial stromal sarcoma.
    Hrynchak M; Horsman D; Salski C; Berean K; Benedet JL
    Cancer Genet Cytogenet; 1994 Oct; 77(1):45-9. PubMed ID: 7923082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas.
    Coosemans A; Nik SA; Caluwaerts S; Lambin S; Verbist G; Van Bree R; Schelfhout V; de Jonge E; Dalle I; Jacomen G; Cassiman JJ; Moerman P; Vergote I; Amant F
    Eur J Cancer; 2007 Jul; 43(10):1630-7. PubMed ID: 17531467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
    Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
    Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine sarcoma.
    Belgrad R; Elbadawi N; Rubin P
    Radiology; 1975 Jan; 114(1):181-8. PubMed ID: 1208858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN; Finkelstein SD; Jones MW
    Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
    Liao Q; Wang J; Han J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.